Enagas SA
11.69
23-12月-24 10:32:48
15 分の遅延
株式
-0.34
-2.79%
本日の幅
11.58 - 12.12
ISIN
ES0130960018
ソース
Cboe
-
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Rating of "Moderate Buy" by Analysts
23 12 2024 09:06:12 提供 Buzz FX
-
CEVA, Inc. (NASDAQ:CEVA) Given Consensus Recommendation of "Buy" by Brokerages
23 12 2024 09:06:12 提供 Buzz FX
-
PotlatchDeltic Co. (NASDAQ:PCH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
23 12 2024 09:06:12 提供 Buzz FX
-
Bay Street May Open With Slightly Negative Bias; GDP, PPI Data In Focus
23 12 2024 09:00:24 提供 Buzz FX
-
Bespoke’s Morning Lineup – 12/23/24 – The Nightmare Before Christmas
23 12 2024 08:56:24 提供 Buzz FX
-
Futures Flat As Markets Wind Down For 2024
23 12 2024 08:46:24 提供 Buzz FX
-
Citigroup Reaffirms Buy Rating for Cosan (NYSE:CSAN)
23 12 2024 08:46:12 提供 Buzz FX
-
Loop Capital Issues Positive Forecast for Klaviyo (NYSE:KVYO) Stock Price
23 12 2024 08:46:12 提供 Buzz FX
-
Canaccord Genuity Group Reiterates Buy Rating for Vertical Aerospace (NYSE:EVTL)
23 12 2024 08:46:12 提供 Buzz FX
-
Datadog (NASDAQ:DDOG) Given New $200.00 Price Target at Loop Capital
23 12 2024 08:41:13 提供 Buzz FX
-
Assam Tea industry facing crisis amid rising costs and declining exports, say ATPA
23 12 2024 08:40:22 提供 Buzz FX
-
Gold News: Fed’s Hawkish Stance Pressures Prices as Holiday Trading Stalls
23 12 2024 08:36:18 提供 Buzz FX
-
Sources: Fed's Barr Seeks Legal Advice Amid Trump Removal Speculation | Newsmax.com
23 12 2024 08:26:25 提供 Buzz FX
-
Viewpoint: China SiMn prices face pressure in 2025
23 12 2024 08:26:25 提供 Buzz FX
-
HC Wainwright Reiterates "Buy" Rating for BrainsWay (NASDAQ:BWAY)
23 12 2024 08:26:12 提供 Buzz FX
-
Lexicon Pharmaceuticals' (LXRX) Hold Rating Reaffirmed at Needham & Company LLC
23 12 2024 08:26:12 提供 Buzz FX
-
Rhythm Pharmaceuticals' (RYTM) Buy Rating Reaffirmed at HC Wainwright
23 12 2024 08:26:12 提供 Buzz FX
-
23 12 2024 08:26:12 提供 Buzz FX
-
HC Wainwright Increases SoundHound AI (NASDAQ:SOUN) Price Target to $26.00
23 12 2024 08:26:12 提供 Buzz FX
-
HC Wainwright Reaffirms "Buy" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)
23 12 2024 08:26:12 提供 Buzz FX